Pooja Desai

Company: Exelixis, Inc.

Job title: Director of Biotherapeutics CMC

Seminars:

11:00am Assessing Lysine vs. Cysteine Conjugation Method for Achieving Enhanced Homogeneity of the Drug Substance in ADCs 11:00 am

Comparing the individual challenges of lysine and cysteine stochastic conjugation and how it affects attributes of the ADC Site-specific vs. stochastic conjugation strategies to achieve controlled drug-to-antibody ratios (DAR) Examining the distinct process development requirements for each conjugation approach to ensure optimal outcomesRead more

day: Day One CMC Track